tirzepatide semaglutide weight loss comparison Could diabetes and drugs treat Alzheimer's disease? Mounjaro and Alzheimer's: Current Evidence

Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies

Abrupt stopping is medically discouraged because it can trigger intense rebound hunger, blood sugar swings in insulin-resistant individuals, and psychological distress from sudden cravings

Patients with certain genetic variants may benefit from staying at a lower but consistent dose, while others respond better to the standard therapeutic range

Discussing your options with your doctor can help navigate through challenges and explore alternative strategies to optimize your weight loss journey

It is not approved or intended for human or animal use

Bachem Holding, the Swiss specialty peptide CDMO, disclosed in its 2024 annual report that GLP-1 peptides including semaglutide represent its single largest and fastest-growing revenue segment, accounting for approximately 31% of group sales